跳至主要内容
临床试验/CTRI/2024/04/066510
CTRI/2024/04/066510已完成3 期

Efficacy and Safety of Polystrain Probiotics for Chronic Abdominal Pain in children aged 7-14 years: A Prospective, Open-labelled, Randomised, Parallel Study

Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2024年5月9日最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
132
试验地点
1
主要终点
1. Changes in pain in study population

研究概览

简要总结

Chronic abdominal pain is a common disorder affecting school-

going children and often results in significantly low attendance rates and high school

absenteeism. Since the pathophysiology of CAP is poorly understood and there is limited

data regarding the efficacy and safety of the few therapeutic options available, management

of CAP in children can be challenging. Probiotics have shown potential as microbiota

modulators in various Gastro Intestinal Disorders. However, there is limited research

available evaluating the efficacy and safety of probiotics in managing CAP in children.

Therefore, this study is undertaken to investigate the effect of polystrain probiotics in

children suffering from chronic abdominal pain.

The eligible patients will be randomly allocated to 2 treatment groups: Group A and Group

B (n=66 in each group)

• Group A will be given Polystrain Probiotics twice a day as an add-on to standard of care

for 2 weeks.

• Group B will be given standard of care for 2 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
7.00 Year(s) 至 14.00 Year(s)(—)
性别
All

入选标准

  • Chronic Abdominal Pain diagnosed according to ROME 4 Criteria.
  • Legally Authorized Representative/Participants willing to give assent/consent for the study.

排除标准

  • Organic pain warning signs (includes age under 5, right upper and right lower abdominal pain, failure to thrive).
  • Having organic disease (urinary tract infection, celiac disease, parasites, etc.) and other chronic diseases.
  • Patient on Antibiotics, Prokinetics.
  • Acute Infection.
  • Undergone abdominal surgery within 1 month.

结局指标

主要结局

1. Changes in pain in study population

时间窗: 2nd week and 4th week

 Severity/Intensity

时间窗: 2nd week and 4th week

 Frequency

时间窗: 2nd week and 4th week

 Duration

时间窗: 2nd week and 4th week

2. Change in Quality of Life (QoL) in study population

时间窗: 2nd week and 4th week

次要结局

  • 1. Number of patients requiring escape treatment(2. Adherence to treatment)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Savita Verma

Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak

研究点 (1)

Loading locations...

相似试验

The efficacy and safety of probiotics in treating... | 临床试验